Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
11025583 | Atherosclerosis | 2018 | 39 Pages |
Abstract
In dialysis patients the YB-1 acetylation status is higher with prevailing diabetes and intima plaque formation. Pro-inflammatory mediators TNFα, IL-6, uPAR, CCL2, M-CSF, progranulin, ANP, and midkine, as well as anti-inflammatory IL-10 are significantly increased in dialysis patients, emphasizing a systemic inflammatory milieu. Strong positive correlations of monocytic YB-1 content are seen with ANP, IP-10, IL-6, and IL-10 serum levels. This is the first study demonstrating an association of cold shock protein YB-1 expression with inflammation in hemodialysis patients.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Lara Ewert, Anja Fischer, Sabine Brandt, Florian G. Scurt, Lars Philipsen, Andreas J. Müller, Matthias Girndt, Ana C. Zenclussen, Jonathan A. Lindquist, Xenia Gorny, Peter R. Mertens,